Calimmune was founded in 2006 based on gene modification and cell delivery technology developed in the labs of Nobel Laureate David Baltimore, Ph.D. (California Institute of Technology), Irvin Chen, Ph.D. (University of California, Los Angeles) and Inder M. Verma, Ph.D. (Salk Institute for Biological Studies).
Timeline
May 2015
Calimmune raises a $15,900,000 series B round from Alexandria Venture Investments, RA Capital Management and Translational Accelerator.
2006
Calimmune was founded by David Baltimore and Louis Breton.
Funding rounds
People
Name
Role
LinkedIn
Further reading
Title
Author
Link
Type
Date
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
CSL Behring
Web
Documentaries, videos and podcasts
Title
Date
Link
Companies
Company
CEO
Location
Products/Services
References
Is a
CompanyCompany attributes
Biotechnology
Genetics
Gene therapy
Healthcare
Stem cell
California
Los Angeles
King of Prussia, Pennsylvania
United StatesCompany status
Active
B2X
B2BFounder
David BaltimoreCrunchbase
Legal name
Calimmune, Inc.
Legal classification
CorporationDate incorporated
2006
Number of Employees (ranges)
5 – 9
Full address
5151 East Broadway Boulevard Suite 1020 Tucson, AZ 85711 United States
CIK number
Mark Solon
RA Capital Management
Alexandria Venture InvestmentsFounded date
January 1, 2006
Total funding amount (USD)
15,900,000
Latest funding round date
May 2015
Latest funding type
Series B roundCategories
Related Topics
Contributors
- 1
Dawson Sewell
Writing about startups. - 2
Blessing Nwodo
Experienced writer - 3
Dushyant Soni
Researcher - 4
Meredith Hanel
Medical Genetics PhD, following life science applications that improve the health of humans and our planet. - 5
Amy Sar
Data acquisition - 6
Henry Ogolla
Passionate about reading and writing. - 7
Wyckliffe Otieno
Dedicated information technology enthusiast. - 8
Dhruv Sharma
Researcher - 9
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME
